The contemporary role of renal mass biopsy in the management of small renal tumors

Frontiers in Oncology

Volumn 2 SEP, Issue , 2012, Pages

  Lim, Amy ^a   O'Neil, Brock ^b   Heilbrun, Marta E ^b   Dechet, Christopher ^b   Lowrance, William T ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Nephrectomy; Renal biopsy; Renal cell carcinoma; Renal mass; Renal neoplasms

Indexed keywords

ARTERIOVENOUS FISTULA; BLEEDING; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; CYTOGENETICS; FINE NEEDLE ASPIRATION BIOPSY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY TUMOR; META ANALYSIS (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL NEPHRECTOMY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TUMOR SEEDING;

EID: 84891645766     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00106     Document Type: Review

References (105)

1. Abel, E. J., Carrasco, A., Culp, S. H., Matin, S. F., Tamboli, P., Tannir, N. M., and Wood, C. G. (2012). Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases. BJU Int. doi: 10.1111/j.1464-410X.2012.11124.x. [Epub ahead of print].
2. Abou Youssif, T., Kassouf, W., Steinberg, J., Aprikian, A. G., Laplante, M. P., and Tanguay, S. (2007). Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer 110, 1010-1014.
3. Abouassaly, R., Lane, B. R., and Novick, A. C. (2008) Active surveillance of renal masses in elderly patients. J. Urol. 180, 505-508. discussion: 508-509.
4. Adley, B. P., Papavero, V., Sugimura, J., Teh, B. T., and Yang, X. J. (2006). Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Anal. Quant. Cytol. Histol. 28, 228-236.
5. Amin, M. B., Crotty, T. B., Tickoo, S. K., and Farrow, G. M. (1997). Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am. J. Surg. Pathol. 21, 1-12.
6. Barocas, D. A., Mathew, S., DelPizzo, J. J., Vaughan, E. D. Jr., Sosa, R. E., Fine, R. G., Akhtar, M., and Scherr, D. S. (2007). Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen. BJU Int. 99, 290-295.
7. Barocas, D. A., Rohan, S. M., Kao, J., Gurevich, R. D., Del Pizzo, J. J., Vaughan, E. D. Jr., Akhtar, M., Chen, Y. T., and Scherr, D. S. (2006). Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis. J. Urol. 176, 1957-1962.
8. Becker, F., Siemer, S., Humke, U., Hack, M., Ziegler, M., and Stockle, M. (2006). Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: long-term survival data of 216 patients. Eur. Urol. 49, 308-313.
9. Beland, M. D., Mayo-Smith, W. W., Dupuy, D. E., Cronan, J. J., and DeLellis, R. A. (2007). Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal masses: should we biopsy all that are indeterminate? Am. J. Roentgenol. 188, 792-797.
10. Berger, A., Kamoi, K., Gill, I. S., and Aron, M. (2009). Cryoablation for renal tumors: current status. Curr. Opin. Urol. 19, 138-142.
11. Blumenfeld, A. J., Guru, K., Fuchs, G. J., and Kim, H. L. (2010). Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade. Urology 76, 610-613.
12. Boorjian, S. A., and Uzzo, R. G. (2009). The evolving management of small renal masses. Curr. Oncol. Rep. 11, 211-217.
13. Caoili, E. M., Bude, R. O., Higgins, E. J., Hoff, D. L., and Nghiem, H. V. (2002). Evaluation of sonographically guided percutaneous core biopsy of renal masses. Am. J. Roentgenol. 179, 373-378.
14. Chawla, S. N., Crispen, P. L., Hanlon, A. L., Greenberg, R. E., Chen, D. Y., and Uzzo, R. G. (2006). The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J. Urol. 175, 425-431.
15. Cheville, J. C., Lohse, C. M., Zincke, H., Weaver, A. L., and Blute, M. L. (2003). Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am. J. Surg. Pathol. 27, 612-624.
16. Choudhary, S., Rajesh, A., Mayer, N. J., Mulcahy, K. A., and Haroon, A. (2009). Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin. Radiol. 64, 517-522.
17. Chow, W. H., Devesa, S. S., Warren, J. L., and Fraumeni, J. F. Jr. (1999). Rising incidence of renal cell cancer in the United States. JAMA 281, 1628-1631.
18. Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., and Levey, A. S. (2007). Prevalence of chronic kidney disease in the United States. JAMA 298, 2038-2047.
19. Crowley, J. D., Shelton, J., Iverson, A. J., Burton, M. P., Dalrymple, N. C., and Bishoff, J. T. (2001). Laparoscopic and computed tomography-guided percutaneous radiofrequency ablation of renal tissue: acute and chronic effects in an animal model. Urology 57, 976-980.
20. Dechet, C. B., Sebo, T., Farrow, G., Blute, M. L., Engen, D. E., and Zincke, H. (1999). Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J. Urol. 162, 1282-1284; discussion 1284-1285.
21. Dechet, C. B., Zincke, H., Sebo, T. J., King, B. F., LeRoy, A. J., Farrow, G. M., and Blute, M. L. (2003). Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J. Urol. 169, 71-74.
22. Dorffner, R., Thurnher, S., Prokesch, R., Bankier, A., Turetschek, K., Schmidt, A., and Lammer, J. (1998). Embolization of iatrogenic vascular injuries of renal transplants: immediate and follow-up results. Cardiovasc. Intervent. Radiol. 21, 129-134.
23. Dulabon, L. M., Lowrance, W. T., Russo, P., and Huang, W. C. (2010). Trends in renal tumor surgery delivery within the United States. Cancer 116, 2316-2321.
24. Frank, I., Blute, M. L., Cheville, J. C., Lohse, C. M., Weaver, A. L., and Zincke, H. (2003). Solid renal tumors: an analysis of pathological features related to tumor size. J. Urol. 170(6 Pt 1), 2217-2220.
25. Garcia, E., and Li, M. (2006). Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Am. J. Clin. Pathol. 125, 392-398.
26. Gazelle, G. S., Haaga, J. R., and Rowland, D. Y. (1992). Effect of needle gauge, level of anticoagulation, and target organ on bleeding associated with aspiration biopsy. Work in progress. Radiology 183, 509-513.
27. Heilbrun, M. E., Yu, J., Smith, K. J., Dechet, C. B., Zagoria, R. J., and Roberts, M. S. (2012). The cost-effectiveness of immediate treatment, percutaneous biopsy and active surveillance for the diagnosis of the small solid renal mass: evidence from a Markov model. J. Urol. 187, 39-43.
28. Heilbrun, M. E., Zagoria, R. J., Garvin, A. J., Hall, M. C., Krehbiel, K., Southwick, A., and Clark, P. E. (2007). CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation. AJR Am. J. Roentgenol. 188, 1500-1505.
29. Herts, B. R. (2000). Imaging guided biopsies of renal masses. Curr. Opin. Urol. 10, 105-109.
30. Heuer, R., Gill, I. S., Guazzoni, G., Kirkali, Z., Marberger, M., Richie, J. P., and de la Rosette, J. J. (2010). A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer. Eur. Urol. 57, 223-232.
31. Higgins, J. P., Shinghal, R., Gill, H., Reese, J. H., Terris, M., Cohen, R. J., Fero, M., Pollack, J. R., van de Rijn, M., and Brooks, J. D. (2003). Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am. J. Pathol. 162, 925-932.
32. Hollingsworth, J. M., Miller, D. C., Daignault, S., and Hollenbeck, B. K. (2006). Rising incidence of small renal masses: a need to reassess treatment effect. J. Natl. Cancer Inst. 98, 1331-1334.
33. Huang, W., Kanehira, K., Drew, S., and Pier, T. (2009). Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study. Appl. Immunohistochem. Mol. Morphol. 17, 12-17.
34. Jayson, M., and Sanders, H. (1998). Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51, 203-205.
35. Jewett, M. A., Mattar, K., Basiuk, J., Morash, C. G., Pautler, S. E., Siemens, D. R., Tanguay, S., Rendon, R. A., Gleave, M. E., Drachenberg, D. E., Chow, R., Chung, H., Chin, J. L., Fleshner, N. E., Evans, A. J., Gallie, B. L., Haider, M. A., Kachura, J. R., Kurban, G., Fernandes, K., and Finelli, A. (2011). Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur. Urol. 60, 39-44.
36. Kark, R. M., Muehrcke, R. C., Pollak, V. E., Pirani, C. L., and Kiefer, J. H. (1958). An analysis of five hundred percutaneous renal biopsies. AMA Arch. Intern. Med. 101, 439-451.
37. Keeley, F. X., Kulp, D. A., Bibbo, M., McCue, P. A., and Bagley, D. H. (1997). Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J. Urol. 157, 33-37.
38. Khan, A. A., Shergill, I. S., Quereshi, S., Arya, M., Vandal, M. T., and Gujral, S. S. (2007). Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists. BMC Urol. 7, 10.
39. Klatte, T., Seligson, D. B., Riggs, S. B., Leppert, J. T., Berkman, M. K., Kleid, M. D., Yu, H., Kabbinavar, F. F., Pantuck, A. J., and Belldegrun, A. S. (2007). Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma. Clin. Cancer Res. 13, 7388-7393.
40. Kopecna, L., Mach, V., and Prochazka, J. (2005). Arteriovenous fistula as a complication of renal biopsy. Bratisl. Lek. Listy 106, 218-220.
41. Kouba, E., Smith, A., McRackan, D., Wallen, E. M., and Pruthi, R. S. (2007). Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J. Urol. 177, 466-470. discussion: 470.
42. Koul, H., Huh, J. S., Rove, K. O., Crompton, L., Koul, S., Meacham, R. B., and Kim, F. J. (2011). Molecular aspects of renal cell carcinoma: a review. Am. J. Cancer Res. 1, 240-254.
43. Kowalczyk, K. J., Hooper, H. B., Linehan, W. M., Pinto, P. A., Wood, B. J., and Bratslavsky, G. (2009). Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J. Urol. 182, 2158-2163.
44. Kunkle, D. A., and Uzzo, R. G. (2008). Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 113, 2671-2680.
45. Kunkle, D. A., Crispen, P. L., Chen, D. Y., Greenberg, R. E., and Uzzo, R. G. (2007). Enhancing renal masses with zero net growth during active surveillance. J. Urol. 177, 849-853. discussion: 853-854.
46. Kuroda, N., Toi, M., Yamamoto, M., Miyazaki, E., Hayashi, Y., Hiroi, M., Shuin, T., and Enzan, H. (2004). Immunohistochemical identification of intracytoplasmic lumens by cytokeratin typing may differentiate renal oncocytomas from chromophobe renal cell carcinomas. Histol. Histopathol. 19, 23-28.
47. Lam, J. S., Leppert, J. T., Figlin, R. A., and Belldegrun, A. S. (2005). Role of molecular markers in the diagnosis and therapy of renal cell carcinoma. Urology 66(Suppl. 5), 1-9.
48. Lane, B. R., Samplaski, M. K., Herts, B. R., Zhou, M., Novick, A. C., and Campbell, S. C. (2008). Renal mass biopsy-a renaissance? J. Urol. 179, 20-27.
49. Lebret, S. C., Newgreen, D. F., Thompson, E. W., and Ackland, M. L. (2007). Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors. Breast Cancer Res. 9, R19.
50. Lechevallier, E., Andre, M., Barriol, D., Daniel, L., Eghazarian, C., De Fromont, M., Rossi, D., and Coulange, C. (2000). Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology 216, 506-510.
51. Lee, C. T., Katz, J., Shi, W., Thaler, H. T., Reuter, V. E., and Russo, P. (2000). Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J. Urol. 163, 730-736.
52. Lee, H. W., Lee, E. H., Lee, C. H., Chang, H. K., and Rha, S. H. (2011). Diagnostic utility of Caveolin-1 and MOC-31 in distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Korean J. Urol. 52, 96-103.
53. Leppert, J. T., Pantuck, A. J., Figlin, R. A., and Belldegrun, A. S. (2007). The role of molecular markers in the staging of renal cell carcinoma. BJU Int. 99(5 Pt B), 1208-1211.
54. Li, G., Feng, G., Gentil-Perret, A., Genin, C., and Tostain, J. (2008). Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. J. Urol. 180, 510-513. discussion: 513-514.
55. Liang, Y. X., He, H. C., Han, Z. D., Bi, X. C., Dai, Q. S., Ye, Y. K., Qin, W. J., Zeng, G. H., Zhu, G., Xu, C. L., and Zhong, W. D. (2009). CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value. Cancer Invest. 27, 788-793.
56. Lowrance, W. T., Larson, S., Asnis-Alibozek, A., LaFrance, N. D., Russo, P., and Divgi, C. R. (2011). "Real-world presurgical characteristics and postsurgical morbidity of 10,404 americans undergoing nephrectomy for renal tumors," in International Kidney Cancer Symposium, (Chicago, IL).
57. Lowrance, W. T., Yee, D. S., Savage, C., Cronin, A. M., O'Brien, M. F., Donat, S. M., Vickers, A., and Russo, P. (2010). Complications after radical and partial nephrectomy as a function of age. J. Urol. 183, 1725-1730.
58. Manno, C., Strippoli, G. F., Arnesano, L., Bonifati, C., Campobasso, N., Gesualdo, L., and Schena, F. P. (2004). Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 66, 1570-1577.
59. Martignoni, G., Pea, M., Chilosi, M., Brunelli, M., Scarpa, A., Colato, C., Tardanico, R., Zamboni, G., and Bonetti, F. (2001). Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod. Pathol. 14, 760-767.
60. Matsell, D. G., Jones, D. P., Boulden, T. F., Burton, E. M., Baum, S. L., and Tonkin, I. L. (1992). Arteriovenous fistula after biopsy of renal transplant kidney: diagnosis and treatment. Pediatr. Nephrol. 6, 562-564.
61. Murphy, W. M., Zambroni, B. R., Emerson, L. D., Moinuddin, S., and Lee, L. H. (1985). Aspiration biopsy of the kidney. Simultaneous collection of cytologic and histologic specimens. Cancer 56, 200-205.
62. Muth, R. G. (1965). The safety of percutaneous renal biopsy: an analysis of 500 consecutive cases. J. Urol. 94, 1-3.
63. Nadel, L., Baumgartner, B. R., and Bernardino, M. E. (1986). Percutaneous renal biopsies: accuracy, safety, and indications. Urol. Radiol. 8, 67-71.
64. Neuzillet, Y., Lechevallier, E., Andre, M., Daniel, L., and Coulange, C. (2004). Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J. Urol. 171, 1802-1805.
65. Nguyen, C. T., and Campbell, S. C. (2008). Salvage of local recurrence after primary thermal ablation for small renal masses. Expert Rev. Anticancer Ther. 8, 1899-1905.
66. Nguyen, M. M., Gill, I. S., and Ellison, L. M. (2006). The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J. Urol. 176(6 Pt 1), 2397-2400. discussion: 2400.
67. Oda, H., Nakatsuru, Y., and Ishikawa, T. (1995). Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Cancer Res. 55, 658-662.
68. Pandharipande, P. V., Gervais, D. A., Hartman, R. I., Harisinghani, M. G., Feldman, A. S., Mueller, P. R., and Gazelle, G. S. (2010). Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology 256, 836-846.
69. Parrish, A. E. (1992). Complications of percutaneous renal biopsy: a review of 37 years' experience. Clin. Nephrol. 38, 135-141.
70. Perez-Ordonez, B., Hamed, G., Campbell, S., Erlandson, R. A., Russo, P., Gaudin, P. B., and Reuter, V. E. (1997). Renal oncocytoma: a clinicopathologic study of 70 cases. Am. J. Surg. Pathol. 21, 871-883.
71. Remzi, M., Katzenbeisser, D., Waldert, M., Klingler, H. C., Susani, M., Memarsadeghi, M., Heinz-Peer, G., Haitel, A., Herwig, R., and Marberger, M. (2007). Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small. BJU Int. 99, 1002-1006.
72. Rosenkrantz, A. B., Hindman, N., Fitzgerald, E. F., Niver, B. E., Melamed, J., and Babb, J. S. (2010). MRI features of renal oncocytoma and chromophobe renal cell carcinoma. Am. J. Roentgenol. 195, W421-W427.
73. Russo, P. (2008). Should elective partial nephrectomy be performed for renal cell carcinoma >4 cm in size? Nat. Clin. Pract. Urol. 5, 482-483.
74. Russo, P., Uzzo, R. G., Lowrance, W. T., Asnis-Alibozek, A., LaFrance, N. D., Libertino, J. A., Pryma, D. A., and Divgi, C. R. (2012). Incidence of benign versus malignant renal tumors in selected studies. J. Clin. Oncol. 30, 92.
75. Rybicki, F. J., Shu, K. M., Cibas, E. S., Fielding, J. R., vanSonnenberg, E., and Silverman, S. G. (2003). Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. Am. J. Roentgenol. 180, 1281-1287.
76. Rybikowski, S., Tomatis, L., Arroua, F., Ragni, E., Rossi, D., and Bastide, C. (2008). [Value of percutaneous kidney biopsy in the management of solid renal tumours less or equal to 4 cm]. Prog. Urol. 18, 337-343.
77. Sahni, V. A., and Silverman, S. G. (2009). Biopsy of renal masses: when and why. Cancer Imaging 9, 44-55.
78. Samplaski, M. K., Zhou, M., Lane, B. R., Herts, B., and Campbell, S. C. (2011). Renal mass sampling: an enlightened perspective. Int. J. Urol. 18, 5-19.
79. Sandlund, J., Oosterwijk, E., Grankvist, K., Oosterwijk-Wakka, J., Ljungberg, B., and Rasmuson, T. (2007). Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma. BJU Int. 100, 556-560.
80. Schmidbauer, J., Remzi, M., Memarsadeghi, M., Haitel, A., Klingler, H. C., Katzenbeisser, D., Wiener, H., and Marberger, M. (2008). Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur. Urol. 53, 1003-1011.
81. Shannon, B. A., Cohen, R. J., de Bruto, H., and Davies, R. J. (2008). The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J. Urol. 180, 1257-1261. discussion: 1261.
82. Shenoy, P. D., Lakhkar, B. N., Ghosh, M. K., and Patil, U. D. (1991). Cutaneous seeding of renal carcinoma by Chiba needle aspiration biopsy. Case report. Acta Radiol. 32, 50-52.
83. Skinner, D. G., Colvin, R. B., Vermillion, C. D., Pfister, R. C., and Leadbetter, W. F. (1971). Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 28, 1165-1177.
84. Slotkin, E. A., and Madsen, P. O. (1962). Complications of renal biopsy: incidence in 5000 reported cases. J. Urol. 87, 13-15.
85. Smaldone, M. C., Kutikov, A., Egleston, B. L., Canter, D. J., Viterbo, R., Chen, D. Y., Jewett, M. A., Greenberg, R. E., and Uzzo, R. G. (2012). Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 118, 997-1006.
86. Smith, E. H. (1991). Complications of percutaneous abdominal fine-needle biopsy. Review. Radiology 178, 253-258.
87. Stephenson, A. J., Hakimi, A. A., Snyder, M. E., and Russo, P. (2004). Complications of radical and partial nephrectomy in a large contemporary cohort. J. Urol. 171, 130-134.
88. Sukov, W. R., Ketterling, R. P., Lager, D. J., Carlson, A. W., Sinnwell, J. P., Chow, G. K., Jenkins, R. B., and Cheville, J. C. (2009). CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma. Hum. Pathol. 40, 1296-1303.
89. Takahashi, M., Rhodes, D. R., Furge, K. A., Kanayama, H., Kagawa, S., Haab, B. B., and Teh, B. T. (2001). Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc. Natl. Acad. Sci. U.S.A. 98, 9754-9759.
90. Tan, H. J., Jacobs, B. L., Hafez, K. S., Montgomery, J. S., Weizer, A. Z., Wood, D. P. Jr., Miller, D. C., and Wolf, J. S. Jr. (2012). Understanding the role of percutaneous biopsy in the management of patients with a small renal mass. Urology 79, 372-377.
91. Tang, S., Li, J. H., Lui, S. L., Chan, T. M., Cheng, I. K., and Lai, K. N. (2002). Free-hand, ultrasound-guided percutaneous renal biopsy: experience from a single operator. Eur. J. Radiol. 41, 65-69.
92. Thompson, R. H., Boorjian, S. A., Lohse, C. M., Leibovich, B. C., Kwon, E. D., Cheville, J. C., and Blute, M. L. (2008). Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J. Urol. 179, 468-471. discussion: 472-473.
93. Thuillier, C., Long, J. A., Lapouge, O., Pasquier, D., Terrier, N., Bocqueraz, F., Cyprien, J., Descotes, J. L., and Rambeaud, J. J. (2008). [Value of percutaneous biopsy for solid renal tumours less than 4 cm in diameter based on a series of 53 cases]. Prog. Urol. 18, 435-439.
94. Tuncali, K., vanSonnenberg, E., Shankar, S., Mortele, K. J., Cibas, E. S., and Silverman, S. G. (2004). Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. Am. J. Roentgenol. 183, 575-582.
95. Tzortzis, G., Kolomodi, D., Stathopoulou, S., Kostakis, A., Michail, S., Pappas, P., and Revenas, K. (1998). Hyperselective renal artery embolisation in the treatment of post-traumatic iatrogenic haematuria: report of two cases. Int. Angiol. 17, 58-61.
96. Varona, A., Blanco, L., Perez, I., Gil, J., Irazusta, J., Lopez, J. I., Candenas, M. L., Pinto, F. M., and Larrinaga, G. (2010). Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent. BMC Cancer 10, 193.
97. Vasudevan, A., Davies, R. J., Shannon, B. A., and Cohen, R. J. (2006). Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy. BJU Int. 97, 946-949.
98. Volpe, A., Kachura, J. R., Geddie, W. R., Evans, A. J., Gharajeh, A., Saravanan, A., and Jewett, M. A. (2007). Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J. Urol. 178, 379-386.
99. Wehle, M. J., and Grabstald, H. (1986). Contraindications to needle aspiration of a solid renal mass: tumor dissemination by renal needle aspiration. J. Urol. 136, 446-448.
100. Wood, B. J., Khan, M. A., McGovern, F., Harisinghani, M., Hahn, P. F., and Mueller, P. R. (1999). Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J. Urol. 161, 1470-1474.
101. Wu, S. Q., Hafez, G. R., Xing, W., Newton, M., Chen, X. R., and Messing, E. (1996). The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma. Cancer 77, 1154-1160.
102. Yao, M., Tabuchi, H., Nagashima, Y., Baba, M., Nakaigawa, N., Ishiguro, H., Hamada, K., Inayama, Y., Kishida, T., Hattori, K., Yamada-Okabe, H., and Kubota, Y. (2005). Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J. Pathol. 205, 377-387.
103. Young, A. N., Amin, M. B., Moreno, C. S., Lim, S. D., Cohen, C., Petros, J. A., Marshall, F. F., and Neish, A. S. (2001). Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am. J. Pathol. 158, 1639-1651.
104. Zhou, M., Roma, A., and Magi-Galluzzi, C. (2005). The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin. Lab. Med. 25, 247-257.
105. Zhu, Q., Shimizu, T., Abo, D., Jin, M., Nagashima, K., and Miyasaka, K. (2006). Magnetic resonance imaging findings and histopathological observations after percutaneous renal cryoablation in the rabbit model. J. Urol. 175, 318-326.